By continuing to use Symptoma®, you confirm you accept the cookies. More on
491601 to 491700 most common queries
List represents a sample of symptoms, diseases, and other queries. Updated weekly.
Hemorrhagic metalloproteinases from snake venoms.
Confronting the neglected problem of snake bite envenoming: the need for a global partnership.
Snake-bites: appraisal of the global situation.
The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths.
CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking.
The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase.
An isogenic haemolysin-deficient mutant of Haemophilus ducreyi lacks the ability to produce cytopathic effects on human foreskin fibroblasts.
Immunopathogenesis of Haemophilus ducreyi infection (chancroid).
Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America.
Genital ulcers in Kenya. Clinical and laboratory study.
Comparison of specimen collection and laboratory techniques for isolation of Haemophilus ducreyi.
A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi.
A hemoglobin-binding outer membrane protein is involved in virulence expression by Haemophilus ducreyi in an animal model.
Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers.
DsrA-deficient mutant of Haemophilus ducreyi is impaired in its ability to infect human volunteers.
Biology of Haemophilus ducreyi.
An isogenic hemoglobin receptor-deficient mutant of Haemophilus ducreyi is attenuated in the human model of experimental infection.
Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection.
Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi.
Standardization of the experimental model of Haemophilus ducreyi infection in human subjects.
Experimental human infection with Haemophilus ducreyi.
Chancroid and Haemophilus ducreyi: an update.
Chancroid and Haemophilus ducreyi.
Overview of sleep & sleep disorders.
Neuroimaging in sleep medicine.
Sleepwalking and sleep terrors in prepubertal children: what triggers them?
Sleep problems in primary school children: comparison between mainstream and special school children.
Movement disorders in sleep: guidelines for differentiating epileptic from non-epileptic motor phenomena arising from sleep.
Hypersensitivity of melatonin suppression in response to light in patients with delayed sleep phase syndrome.
Sleep disturbances in prepubertal children with attention deficit hyperactivity disorder: a home polysomnography study.
Review of the possible relationship and hypothetical links between attention deficit hyperactivity disorder (ADHD) and the simple sleep related movement disorders, parasomnias, hypersomnias, and circadian rhythm disorders.
bowel sounds, Crohn's Disease, Left Lower Quadrant Pain, Tympanitic Abdomen
Prevalence of sleep disturbance and hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population.
Fragile X-Associated Tremor - Ataxia Syndrome, Mucoid Nasal Discharge
Excessive daytime sleepiness and sleep complaints among children with epilepsy.
Health-related quality of life among children presenting to a pediatric sleep disorders clinic.
Sleep problems in children with attention-deficit/hyperactivity disorder: impact of subtype, comorbidity, and stimulant medication.
Central pattern generators for a common semiology in fronto-limbic seizures and in parasomnias. A neuroethologic approach.
Parasomnia among psychiatric outpatients: a clinical, epidemiologic, cross-sectional study.
Development of parasomnias from childhood to early adolescence.
Children's sleep and adjustment over time: the role of socioeconomic context.
Early manifestations of restless legs syndrome in childhood and adolescence.
Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis.
Insights from studying human sleep disorders.
Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs.
The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function.
Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy.
Narcolepsy: a key role for hypocretins (orexins)
The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder.
Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.
Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.
The epidemiology of narcolepsy.
Running promotes wakefulness and increases cataplexy in orexin knockout mice.
Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin.
Comparison of the results of the Epworth Sleepiness Scale and the Multiple Sleep Latency Test.
A consensus definition of cataplexy in mouse models of narcolepsy.
Validation of a cataplexy questionnaire in 983 sleep-disorders patients.
Locus coeruleus neurons: cessation of activity during cataplexy.
Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset.
HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.
Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.
Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior.
Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups.
Incidence of second primary tumours among childhood cancer survivors.
Class III beta-tubulin in human development and cancer.
Characteristics of stem cells from human neuroblastoma cell lines and in tumors.
Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis.
Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.
anemia, fatigue, bone pain, renal blood, fatty liver, weight gain, benign nodules
Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies.
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.
Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families.
Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8.
The molecular and genetic basis of neurological tumours.
IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies.
Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF.
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system.
Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.
The WHO classification of tumors of the nervous system.
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes.
Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation.
CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth.
Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation.
RET activation by germline MEN2A and MEN2B mutations.
Germline mutation of RET codon 883 in two cases of de novo MEN 2B.
Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation.
The Ret receptor protein tyrosine kinase associates with the SH2-containing adapter protein Grb10.
Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations.
Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease.
[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium.
Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation.
A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins.
ZD6474 suppresses oncogenic RET isoforms in a Drosophila model for type 2 multiple endocrine neoplasia syndromes and papillary thyroid carcinoma.
Chemical genetic discovery of targets and anti-targets for cancer polypharmacology.
Parent-of-origin effects in multiple endocrine neoplasia type 2B.